China Biologic Products Income from Cont. Ops Quarterly
China Biologic Products Income from Cont. Ops Quarterly Chart
China Biologic Products Historical Income from Cont. Ops Quarterly DataPro Data Export
There is no data for the selected date range.
About Income from Continuing Operations
Income Statement line item that does not account extraordinary items and discontinued operations. This metric is frequently used because it excludes items that are unlikely to happen the next reporting period.
For instance, if MSFT had five billion in Income, and 2 billion in an exceptional item charge, its income would be a reported 3 billion. Because the exceptional charge is unlikely to be repeated in the next quarter, some investors prefer to see what MSFT's income was BEFORE charges.
View Income from Cont. Ops Quarterly for CBPO.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.Get Started Now
Already a YCharts Pro Gold Member? Sign in here.
CBPO Income from Cont. Ops Quarterly Benchmarks
|Acorda Therapeutics||Go Pro|
|Vanda Pharmaceuticals||Go Pro|
CBPO Income from Cont. Ops Quarterly Rankings
1835 of 8011
136 of 687 in Healthcare
20 of 248 in Biotechnology
CBPO Income from Cont. Ops Quarterly Range, Past 5 Years
|Minimum||Go Pro||Sep 2011|
|Maximum||Go Pro||Jun 2011|
PR Newswire May 24
PR Newswire May 8
PR Newswire May 2